TY  - GEN
A1  - Judd, A
A1  - Collins, J
A1  - Haile-Selassie, H
A1  - Rakhamnina, N
A1  - Sturkenboom, M
ID  - discovery10063009
AV  - restricted
TI  - Module 10:
Pharmacovigilance, in: WHO Research Toolkit for Paediatric Antiretroviral Drug and Formulation Development
N1  - This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO (CC BY-NC-SA 3.0 IGO).
Y1  - 2018/06/30/
UR  - https://www.who.int/publications/i/item/9789241514361
N2  - This section introduces the concepts of
pharmacovigilance and adverse drug reactions,
discusses the burden of adverse drug reactions
for children and explains the importance of
pharmacovigilance in the context of antiretroviral
therapy (ART).
PB  - World Health Organization (WHO)
ER  -